Atellica CH Total Bilirubin_2 & Direct Bilirubin 2 (2020-02-12)
- Starting date:
- February 12, 2020
- Posting date:
- May 1, 2020
- Type of communication:
- Medical Device Recall
- Subcategory:
- Medical Device
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Medical Devices
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-72917
Last updated: 2020-05-01
Affected Products
A. Atellica CH Total Bilirubin_2
B. Atellica CH Direct Bilirubin 2
Reason
Siemens Healthcare Diagnostics has become aware that the United Kingdom Medicines and Healthcare Products Regulatory Agency published an alert to healthcare professionals informing them that laboratory tests for bilirubin should be monitored for patients who take the drug eltrombopag due to the potential for discordant results.
Affected products
A. Atellica CH Total Bilirubin_2
Lot or serial number
More than 10 numbers, contact manufacturer.
Model or catalog number
- 2188064
- 2189346
- 11097531
Companies
- Manufacturer
-
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave
Tarrytown
10591
New York
UNITED STATES
B. Atellica CH Direct Bilirubin 2
Lot or serial number
More than 10 numbers, contact manufacturer.
Model or catalog number
- 2188390
- 2189494
- 11097532
Companies
- Manufacturer
-
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave
Tarrytown
10591
New York
UNITED STATES